Remove 2006 Remove Biosimilars Remove Packaging
article thumbnail

Sagent, Qilu partner to commercialise complex injectable products in US

Pharmaceutical Business Review

” Sagent Pharmaceuticals, established in 2006, is a provider of generic and specialty pharmaceuticals. With a portfolio exceeding 100 products, Sagent offers a wide range of options across various therapeutic categories, formulations, and packaging configurations, such as vials, syringes, and premix bags.

Dosage 52
article thumbnail

Sandoz receives approval by EC for Hyrimoz® high-concentration formulation

LifeProNow

April 3, 2023 : “Sandoz, a global leader in off-patent (generic and biosimilar) medicines announced that the European Commission (EC) granted marketing authorization in the European Union (EU) for a citrate-free high concentration formulation (HCF; 100 mg/mL) of its biosimilar Hyrimoz ® (adalimumab).

article thumbnail

Exclusive Coverage: Global PHT Expo & Summit 2023

PharmaShots

Manan Sharma- “as from the technology side I will start with the recently used cases like the government of India has already made it mandatory for around 300 drugs to have their barcode on the packaging to track and trace the information of the drugs. class that received its FDA approval in Oct’2006 for T2D.